|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn668208514 |
003 |
OCoLC |
005 |
20231117044446.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
101005s2010 enka ob 000 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d CDX
|d OCLCQ
|d UKMGB
|d DKDLA
|d OCLCQ
|d OCLCO
|d OCLCF
|d UKDOC
|d OCLCQ
|d N$T
|d YDXCP
|d E7B
|d CUS
|d EBLCP
|d MERUC
|d MHW
|d IDEBK
|d OCLCQ
|d U3W
|d D6H
|d WYU
|d LEAUB
|d OCLCQ
|d S2H
|d OCLCO
|d INARC
|d OCLCQ
|d OCLCO
|
016 |
7 |
|
|a 015594196
|2 Uk
|
019 |
|
|
|a 689035323
|a 728755985
|a 768330128
|
020 |
|
|
|a 9780123849649
|
020 |
|
|
|a 0123849640
|
020 |
|
|
|a 9780123849656
|q (electronic bk.)
|
020 |
|
|
|a 0123849659
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)668208514
|z (OCoLC)689035323
|z (OCoLC)728755985
|z (OCoLC)768330128
|
050 |
|
4 |
|a RS380
|b .M57 2010
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|2 22
|
100 |
1 |
|
|a Misra, Ambikanandan.
|
245 |
1 |
0 |
|a Challenges in delivery of therapeutic genomics and proteomics /
|c Misra Ambikanandan.
|
260 |
|
|
|a Oxford :
|b Elsevier,
|c 2010.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Elsevier insights
|
520 |
|
|
|a Delivery of therapeutic proteomics and genomics represent an important area of drug delivery research. Genomics and proteomics approaches could be used to direct drug development processes by unearthing pathways involved in disease pathogenesis where intervention may be most successful. This book describes the basics of genomics and proteomics and highlights the various chemical, physical and biological approaches to protein and gene delivery. Covers a diverse array of topics from basic sciences to therapeutic applications of proteomics and genomics delivery Of interest to researchers in both academia and industry Highlights what's currently known and where further research is needed.
|
505 |
0 |
|
|a The Cell -- Gene Delivery : Challenges and Opportunities -- Physical Methods of Gene Delivery -- Gene Delivery Using Chemical Methods -- Gene Delivery Using Viral Vectors -- Applications of Gene Therapy -- Antisense Oligonucleotides and Rna Interference -- Proteomics -- Protein and Peptide Delivery Through Respiratory Pathway -- Oral Delivery of Proteins and Peptides: Concepts and Applications -- Parenteral delivery of peptides and proteins -- Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine and Rectal.
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references.
|
650 |
|
0 |
|a Pharmaceutical biotechnology.
|
650 |
|
0 |
|a Pharmacogenomics.
|
650 |
|
0 |
|a Protein drugs
|x Design.
|
650 |
|
0 |
|a Drug delivery systems.
|
650 |
|
2 |
|a Drug Delivery Systems
|0 (DNLM)D016503
|
650 |
|
6 |
|a Biotechnologie pharmaceutique.
|0 (CaQQLa)201-0229592
|
650 |
|
6 |
|a Pharmacog�enomique.
|0 (CaQQLa)201-0322837
|
650 |
|
6 |
|a Syst�emes d'administration de m�edicaments.
|0 (CaQQLa)000260397
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug delivery systems
|2 fast
|0 (OCoLC)fst00898667
|
650 |
|
7 |
|a Pharmaceutical biotechnology
|2 fast
|0 (OCoLC)fst01060106
|
650 |
|
7 |
|a Pharmacogenomics
|2 fast
|0 (OCoLC)fst01060245
|
650 |
|
7 |
|a Protein drugs
|x Design
|2 fast
|0 (OCoLC)fst01079680
|
776 |
0 |
8 |
|i Print version:
|a Misra, Ambikanandan.
|t Challenges in delivery of therapeutic genomics and proteomics.
|d Oxford : Elsevier, 2010
|z 9780123849649
|w (OCoLC)646393829
|
830 |
|
0 |
|a Elsevier insights.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123849649
|z Texto completo
|